Thursday, February 22, 2024
wellness India Expo
Home Tags Durvalumab

Tag: Durvalumab

AstraZeneca’s Durvalumab receives CDSCO approval in India

The product is used for treatment of patients with locally advanced or metastatic Biliary Tract Cancer

AstraZeneca receives marketing permission for Durvalumab (ImfinziTM) in India

Durvalumab is the only immunotherapy approved for patients with unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) and was granted US FDA ‘breakthrough therapy’ designation on July 31, 2017.....................